Cargando…
A new initiative for the development of new diagnostic tests for human African trypanosomiasis
Human African trypanosomiasis is a threat to millions of people living in sub-Saharan countries and is fatal unless treated. At present, the serological and parasitological tests used in the field for diagnosis of sleeping sickness have low specificity and sensitivity. There is clearly an urgent nee...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1464096/ https://www.ncbi.nlm.nih.gov/pubmed/16638141 http://dx.doi.org/10.1186/1475-9292-5-1 |
_version_ | 1782127534881636352 |
---|---|
author | Steverding, Dietmar |
author_facet | Steverding, Dietmar |
author_sort | Steverding, Dietmar |
collection | PubMed |
description | Human African trypanosomiasis is a threat to millions of people living in sub-Saharan countries and is fatal unless treated. At present, the serological and parasitological tests used in the field for diagnosis of sleeping sickness have low specificity and sensitivity. There is clearly an urgent need for accurate tools for both diagnosis and staging of the disease. The Foundation for Innovative New Diagnostics and the World Health Organization have announced that they will collaborate to develop and evaluate new diagnostic tests for human African trypanosomiasis. |
format | Text |
id | pubmed-1464096 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-14640962006-05-20 A new initiative for the development of new diagnostic tests for human African trypanosomiasis Steverding, Dietmar Kinetoplastid Biol Dis Focus Human African trypanosomiasis is a threat to millions of people living in sub-Saharan countries and is fatal unless treated. At present, the serological and parasitological tests used in the field for diagnosis of sleeping sickness have low specificity and sensitivity. There is clearly an urgent need for accurate tools for both diagnosis and staging of the disease. The Foundation for Innovative New Diagnostics and the World Health Organization have announced that they will collaborate to develop and evaluate new diagnostic tests for human African trypanosomiasis. BioMed Central 2006-04-25 /pmc/articles/PMC1464096/ /pubmed/16638141 http://dx.doi.org/10.1186/1475-9292-5-1 Text en Copyright © 2006 Steverding; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Focus Steverding, Dietmar A new initiative for the development of new diagnostic tests for human African trypanosomiasis |
title | A new initiative for the development of new diagnostic tests for human African trypanosomiasis |
title_full | A new initiative for the development of new diagnostic tests for human African trypanosomiasis |
title_fullStr | A new initiative for the development of new diagnostic tests for human African trypanosomiasis |
title_full_unstemmed | A new initiative for the development of new diagnostic tests for human African trypanosomiasis |
title_short | A new initiative for the development of new diagnostic tests for human African trypanosomiasis |
title_sort | new initiative for the development of new diagnostic tests for human african trypanosomiasis |
topic | Focus |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1464096/ https://www.ncbi.nlm.nih.gov/pubmed/16638141 http://dx.doi.org/10.1186/1475-9292-5-1 |
work_keys_str_mv | AT steverdingdietmar anewinitiativeforthedevelopmentofnewdiagnostictestsforhumanafricantrypanosomiasis AT steverdingdietmar newinitiativeforthedevelopmentofnewdiagnostictestsforhumanafricantrypanosomiasis |